Robust resources at the ready.

Analytical Methods for Bioanalysis

Contact Us

Validated Bioanalytical Assays to Support Your COVID-19 Therapy Development

Saving precious time in meeting urgent demand

Abacavir / Darunavir / Etravirine / Lamivudine / Nevirapine / Saquinavir / Stavudine / Zidovudine – combo method   Maraviroc    
Amprenavir   Raltegravir    
Amprenavir / Ritonavir – combo method   Ribavirin    
Azithromycin   Rilpivirine    
Emtricitabine   Ritonavir    
Emtricitabine / Tenofovir – combo method   Tenofovir    
Lopinavir / Ritonavir – combo method        
Coronavirus

Proprietary methods approved for use in COVID-19 trials:

Hydroxychloroquine

From preclinical research through clinical development, we’re here to help you at every stage of the continuum to deliver accurate, on-time results and advance your program. To meet your program’s requirements, our GLP, nonproprietary methods have been developed according to FDA Crystal City and current regulatory guidelines. You’ll benefit from our expert scientific team and state-of-the-art technologies to support your DDI, concomitant drugs and generics studies.

For your convenience, we’ve organized our nonproprietary bioanalytical methods into two categories: single analyte methods and multi-analyte methods, accessible in the PDFs below. These lists now include therapeutic area and disease.

Let's start the conversation

Contact Us